scholarly article | Q13442814 |
P356 | DOI | 10.3109/10428194.2013.856426 |
P698 | PubMed publication ID | 24144314 |
P50 | author | Dario Consonni | Q30089988 |
Agostino Cortelezzi | Q56461136 | ||
Anna Zaninoni | Q59150863 | ||
Gianluigi Reda | Q59647804 | ||
Lucia Nobili | Q59679402 | ||
Francesca Imperiali | Q63988994 | ||
Bruno Fattizzo | Q67414495 | ||
P2093 | author name string | Alberto Zanella | |
Wilma Barcellini | |||
Silvia Lonati | |||
P2860 | cites work | Toll-like receptor signalling | Q24570126 |
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines | Q24616084 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Chronic lymphocytic leukemia | Q28236621 | ||
Defining criteria for autoimmune diseases (Witebsky's postulates revisited) | Q28255257 | ||
Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis | Q28591514 | ||
Statistical Methods in Medical Research | Q29013788 | ||
Autoimmune complications of chronic lymphocytic leukemia | Q33370863 | ||
Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors. | Q33399624 | ||
Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation | Q33494116 | ||
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis | Q34282319 | ||
Biology of chronic lymphocytic leukemia | Q34329516 | ||
Abnormal T-cell function in B-cell chronic lymphocytic leukaemia | Q35104347 | ||
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients | Q35528659 | ||
Inferences, questions and possibilities in Toll-like receptor signalling | Q35829752 | ||
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies | Q36083000 | ||
Signaling in B cells via Toll-like receptors | Q36123183 | ||
Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors | Q36465271 | ||
TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation | Q36585700 | ||
Cytokine-producing B lymphocytes-key regulators of immunity | Q36775913 | ||
TLR signaling in B-cell development and activation. | Q37729362 | ||
Prognostic factors in chronic lymphocytic leukemia-what do we need to know? | Q37801267 | ||
Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. | Q40005494 | ||
Cutting edge: Lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8+ T cell response | Q42631213 | ||
Autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia is associated with IgVH status | Q42739945 | ||
In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia. | Q44201018 | ||
Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia. | Q44366697 | ||
Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells | Q46845154 | ||
Toll-like receptor stimulation as a third signal required for activation of human naive B cells. | Q53632191 | ||
Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. | Q54505699 | ||
P433 | issue | 8 | |
P921 | main subject | leukemia | Q29496 |
toll-like receptor | Q408004 | ||
lymphocyte | Q715347 | ||
P304 | page(s) | 1768-1773 | |
P577 | publication date | 2014-02-14 | |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression | |
P478 | volume | 55 |
Q33439333 | A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia |
Q92923519 | Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs |
Q93054434 | Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects |
Q38727874 | Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence? |
Q39092548 | Current Knowledge of Necrotizing Enterocolitis in Preterm Infants and the Impact of Different Types of Enteral Nutrition Products. |
Q51712946 | Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis. |
Q37677971 | The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia. |
Search more.